Skip to content

Cardiac Function in Severe Aneurysmal Subarachnoid Haemorrhage Patients

Speckle Tracking Assessment of Cardiac Function in Severe Aneurysmal Subarachnoid Haemorrhage and Impact on Neurologic Outcome (SPLASH)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01801800
Acronym
SPLASH
Enrollment
80
Registered
2013-03-01
Start date
2012-01-31
Completion date
2013-12-31
Last updated
2014-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aneurysmal Subarachnoid Haemorrhage, World Neurosurgeon Federation Score ≥ III

Keywords

Aneurysmal subarachnoid haemorrhage

Brief summary

Cardiac dysfunction can occur in aneurysmal subarachnoid haemorrhage and might impact patient's neurologic outcome Condition Aneurysmal subarachnoid haemorrhage World Neurosurgeon Federation Score ≥ III

Detailed description

Trans-thoracic echocardiography on day 1, day 3 and day 7 Speckle-Tracking of echocardiographic loops by a cardiologist blinded to the patient's management and outcome

Interventions

PROCEDUREEchocardiography

Speckle-Tracking of echocardiographic loops by a cardiologist blinded to the patient's management and outcome

Sponsors

Nantes University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
15 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Aneurysmal subarachnoid haemorrhage * World Neurosurgeon Federation Score ≥ III * Written information to next-of-kin and patients when possible

Exclusion criteria

* History of myocardial infarction, chronic heart failure with NYHA ≥ 2, major heart surgery * Lack of acoustic window to perform trans-thoracic echocardiography

Design outcomes

Primary

MeasureTime frameDescription
Neurologic outcome3 monthsmodified Rankin Scale (mRS). Poor neurological outcome was considered as death or severe disability (mRS 5-6).

Secondary

MeasureTime frame
Correlation between cardiac enzymes (NT-proBNP, troponin T US) and cardiac strainDay 1
Correlation between EKG findings and cardiac strainDay 1
Time to amines discontinuationDuring Intensive Care Unit stay, expected average 17 days
Correlation between cardiac strain on day 1 and Left Ventricular Ejection fractionDay 1
Length of ICU stayDuration of ICU stay, expected average 17 days
Correlation between Cardiac function and Mechanical VentilationDay1, day3, day7 and extubation time expected average 15 days
Correlation between Cardiac function and ICU length of stayDay1, day3, day 7 and end of stay in ICU expected average 17 days
Duration of mechanical ventilationDuration of mechanical ventilation, expected average 15 days

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026